Building An Effective Contamination Control Strategy For Final Sterile Filtration
The current expectation for a contamination control strategy (CCS) is that it becomes a single reference point that defines critical control points through data-informed risk assessments, ultimately demonstrating process control. Additionally, CCS is intended to be a living document that undergoes regular reviews to promote continuous improvement, thereby further reducing contamination risks as process understanding evolves.
Final sterile filtration is crucial in aseptic manufacturing, and end-users must understand the key factors when implementing a CCS for sterile filtration and the types of risk assessments necessary.
Watch this webinar to gain insight into important considerations for final sterile filtration throughout product development and for performing pre-use post-sterilization integrity testing (PUPSIT).
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.